Saito K, Mukai K, Kaweewan I, Nakagawa H, Hosaka T, Kodani S
J Microbiol. 2023; 61(6):641-648.
PMID: 37306831
DOI: 10.1007/s12275-023-00059-z.
Fu Y, Xu Y, Ruijne F, Kuipers O
FEMS Microbiol Rev. 2023; 47(3).
PMID: 37096385
PMC: 10373908.
DOI: 10.1093/femsre/fuad017.
A M van Beekveld R, Derks M, Kumar R, Smid L, Maass T, Medeiros-Silva J
Chemistry. 2022; 28(70):e202202472.
PMID: 36098094
PMC: 10092488.
DOI: 10.1002/chem.202202472.
Ongpipattanakul C, Desormeaux E, DiCaprio A, van der Donk W, Mitchell D, Nair S
Chem Rev. 2022; 122(18):14722-14814.
PMID: 36049139
PMC: 9897510.
DOI: 10.1021/acs.chemrev.2c00210.
Bobeica S, Zhu L, Acedo J, Tang W, van der Donk W
Chem Sci. 2021; 11(47):12854-12870.
PMID: 34094481
PMC: 8163290.
DOI: 10.1039/d0sc01651a.
Mechanisms of action of ribosomally synthesized and posttranslationally modified peptides (RiPPs).
Cao L, Do T, Link A
J Ind Microbiol Biotechnol. 2021; 48(3-4).
PMID: 33928382
PMC: 8183687.
DOI: 10.1093/jimb/kuab005.
Mathermycin, an anti-cancer molecule that targets cell surface phospholipids.
Cheng C, Chen H, Tong L, Li Z, Yang Y, Wu S
Toxicol Appl Pharmacol. 2021; 413:115410.
PMID: 33476679
PMC: 7928219.
DOI: 10.1016/j.taap.2021.115410.
Interactions of Cinnamycin-Immobilized Gold Nanorods with Biomimetic Membranes.
Lee G, Park J
J Membr Biol. 2019; 253(1):37-42.
PMID: 31754751
DOI: 10.1007/s00232-019-00103-3.
Structure and Dynamics of Cinnamycin-Lipid Complexes: Mechanisms of Selectivity for Phosphatidylethanolamine Lipids.
Vestergaard M, Berglund N, Hsu P, Song C, Koldso H, Schiott B
ACS Omega. 2019; 4(20):18889-18899.
PMID: 31737850
PMC: 6854821.
DOI: 10.1021/acsomega.9b02949.
Substrate-assisted enzymatic formation of lysinoalanine in duramycin.
An L, Cogan D, Navo C, Jimenez-Oses G, Nair S, van der Donk W
Nat Chem Biol. 2018; 14(10):928-933.
PMID: 30177849
PMC: 6372306.
DOI: 10.1038/s41589-018-0122-4.
Ribosomal Natural Products, Tailored To Fit.
Funk M, van der Donk W
Acc Chem Res. 2017; 50(7):1577-1586.
PMID: 28682627
PMC: 5603336.
DOI: 10.1021/acs.accounts.7b00175.
Targeting Membrane Lipid a Potential Cancer Cure?.
Tan L, Chan K, Pusparajah P, Lee W, Chuah L, Khan T
Front Pharmacol. 2017; 8:12.
PMID: 28167913
PMC: 5253362.
DOI: 10.3389/fphar.2017.00012.
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.
Repka L, Chekan J, Nair S, van der Donk W
Chem Rev. 2017; 117(8):5457-5520.
PMID: 28135077
PMC: 5408752.
DOI: 10.1021/acs.chemrev.6b00591.
Insights into the Biosynthesis of Duramycin.
Huo L, Okesli A, Zhao M, van der Donk W
Appl Environ Microbiol. 2016; 83(3).
PMID: 27864176
PMC: 5244291.
DOI: 10.1128/AEM.02698-16.
A novel mechanism of immunity controls the onset of cinnamycin biosynthesis in Streptomyces cinnamoneus DSM 40646.
ORourke S, Widdick D, Bibb M
J Ind Microbiol Biotechnol. 2016; 44(4-5):563-572.
PMID: 27858169
PMC: 5408092.
DOI: 10.1007/s10295-016-1869-9.
Insights into the evolution of lanthipeptide biosynthesis.
Yu Y, Zhang Q, van der Donk W
Protein Sci. 2013; 22(11):1478-89.
PMID: 24038659
PMC: 3831664.
DOI: 10.1002/pro.2358.
Illuminating the lipidome to advance biomedical research: peptide-based probes of membrane lipids.
Gao J, Zheng H
Future Med Chem. 2013; 5(8):947-59.
PMID: 23682570
PMC: 3905809.
DOI: 10.4155/fmc.13.66.
The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics.
Suarez J, Edwards A, McBride S
J Bacteriol. 2013; 195(11):2621-31.
PMID: 23543720
PMC: 3676062.
DOI: 10.1128/JB.00166-13.
Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.
Knerr P, van der Donk W
J Am Chem Soc. 2012; 134(18):7648-51.
PMID: 22524291
PMC: 3349288.
DOI: 10.1021/ja302435y.
Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.
Velasquez J, Zhang X, van der Donk W
Chem Biol. 2011; 18(7):857-67.
PMID: 21802007
PMC: 3161514.
DOI: 10.1016/j.chembiol.2011.05.007.